Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia
NCT ID: NCT01174797
Last Updated: 2013-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
186 participants
OBSERVATIONAL
2010-06-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome
NCT01137513
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy
NCT00589849
Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment
NCT06269874
Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3
NCT05426408
Ventricular Arrhythmia After Myocarditis in Sportsman
NCT03842592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients being evaluated for active ischemia
Subjects with known or suspected CAD who are scheduled to undergo routine exercise MPI or stress echocardiography for the detection of active ischemia are eligible for enrollment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and capable of providing informed consent
* Willing and capable of undergoing a SPECT MPI exercise test (or stress echo) at an approved clinical investigational center
* In normal sinus rhythm at the time of the exercise test
* A life expectancy of more than 6 months
Exclusion Criteria
* Left bundle branch block (precludes ST segment measurement)
* Pacemaker-dependent
* Life expectancy of less than 6 months
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cambridge Heart Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edward J Kosinski, MD
Role: PRINCIPAL_INVESTIGATOR
Connecticut Clinical Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Connecticut Clinical Research, LLC
Bridgeport, Connecticut, United States
Northwest Houston Heart Center
Tomball, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
60-0001-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.